Assessment of the anti-allodynic efficacy of a glycine transporter 2 inhibitor relative to pregabalin and duloxetine in a rat model of prostate cancer-induced bone pain.
Mohammad Zafar ImamAndy KuoJanet R NicholsonLaura CorradiniMaree T SmithPublished in: Pharmacological reports : PR (2020)
Oral administration of this GlyT2 inhibitor evoked partial pain relief in PCIBP rats and did not evoke central nervous system side effects in contrast to GlyT2 inhibitors reported by others.